文献速递外周动脉疾病

间歇性跛行真空疗法的随机对照试验

Randomized controlled trial of vacuum therapy for intermittent claudication.
PubMed 文献 · J Vasc Surg · 2019-11-02

荷兰三家综合医院2015年12月至2017年7月招募间歇性跛行患者,随机分为干预组(-50 mBar间歇真空疗法)和对照组(-5 mBar假治疗),均接受标准化监督运动疗法。78例随机,70例意向性分析,12周时两组最大平板行走距离变化无显著差异(+250 vs +335米,P=.109),真空疗法未带来额外获益。

要点

  • 间歇真空疗法联合监督运动疗法未额外改善跛行患者行走距离。
  • 12周最大平板行走距离变化干预组+250米,对照组+335米,P=.109。
  • 功能行走距离、6分钟步行试验、步行能力和生活质量两组改善程度相当。

核心结论

  • 在标准化监督运动疗法基础上,间歇真空疗法对间歇性跛行患者未产生额外有益效果。

研究设计与样本

  • 随机对照试验,从荷兰三家综合医院招募间歇性跛行患者,随机分为间歇真空疗法组(-50 mBar)和假治疗组(-5 mBar),均接受标准化监督运动疗法。
  • 共78例患者随机,70例纳入意向性分析(对照组34例,干预组36例);干预为6周内12次、每次30分钟的真空治疗。

主要发现

  • 12周最大平板行走距离中位变化:对照组+335(205-756)米,干预组+250(77-466)米,P=.109。
  • 12周功能平板行走距离中位变化:对照组+230(135-480)米,干预组+188(83-389)米,P=.233。
  • 6分钟步行试验平均变化:对照组+36±48米,干预组+55±63米,P=.823。
  • 步行能力和生活质量两组改善程度相同。

临床怎么用

  • 对于接受标准化监督运动疗法的间歇性跛行患者,不应常规添加间歇真空疗法以期望额外改善行走能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The "gold standard" treatment of intermittent claudication (IC) is supervised exercise therapy (SET). Intermittent vacuum therapy (IVT) has recently been promoted as an additional treatment of IC. During IVT, negative pressure and atmospheric pressure are alternatingly applied to the lower extremities, possibly resulting in improved circulation. The aim of this study was to determine a potential additional effect of IVT in IC patients undergoing a standardized SET program. METHODS: IC patients were recruited from three Dutch general hospitals between December 2015 and July 2017. They received a standardized SET program but were also randomly assigned to an intervention group receiving an IVT treatment (-50 mBar negative pressure) or a control group receiving a sham treatment (-5 mBar negative pressure). IVT was provided in a dedicated clinic during 12 sessions of 30 minutes during a 6-week period. The primary outcome measure was a change in maximal treadmill walking distance. Secondary outcome measures were a change in functional treadmill walking distance, 6-minute walk test, ambulatory ability, and quality of life. RESULTS: A total of 78 patients were randomized, of whom 70 were available for intention-to-treat analysis (control, n = 34; intervention, n = 36). At 6 and 12 weeks, increases in walking distance were of equal magnitude. Median (interquartile range) change in maximal treadmill walking distance during 12 weeks was +335 (205-756) meters in control patients and +250 (77-466) meters in intervention patients (P = .109), whereas functional treadmill walking distance increased +230 (135-480) meters and +188 (83-389) meters (P = .233), respectively. Mean ± standard deviation change in the 6-minute walk test was +36 ± 48 meters and +55 ± 63 meters (P = .823), respectively. Ambulatory ability and quality of life improved equally in both groups. CONCLUSIONS: IVT does not confer any additional beneficial effects in IC patients undergoing a standardized SET program.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hageman D, Fokkenrood HJP, van Deursen BAC, et al. Randomized controlled trial of vacuum therapy for intermittent claudication. J Vasc Surg. 2019. PMID: 31690523. doi:10.1016/j.jvs.2019.08.239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。